Baseline characteristics of the study sample, according to treatment group
| Variable | Ticagrelor n=9333 | Clopidogrel n=9291 |
| Age, years (median, IQR) | 62.0 (54.0–71.0) | 62.0 (54.0–71.0) |
| Age >75 years | 1396 (15.0%) | 1482 (16.0%) |
| Female | 2655 (28.4%) | 2633 (28.3%) |
| Weight (median, IQR) | 80.0 (70.0–90.0) | 80.0 (70.0–90.0) |
| Weight <60 kg | 652 (7.0%) | 660 (7.1%) |
| BMI (median, IQR) | 27.4 (24.7–30.5) | 27.3 (24.7–30.4) |
| Race | ||
| White | 8566 (91.8%) | 8511 (91.6%) |
| Black | 115 (1.2%) | 114 (1.2%) |
| Asian | 542 (5.8%) | 554 (6.0%) |
| Other | 109 (1.2%) | 112 (1.2%) |
| Current smoker | 2326 (24.9%) | 3318 (35.7%) |
| Diabetes prevalence | 2326 (24.9%) | 2336 (25.1%) |
BMI, body mass index.